Cargando…
Adjunct Intravitreous Triamcinolone Acetonide in the Treatment of Diabetic Macular Edema with Anti-VEGF Agents
Aims. To compare visual and anatomic outcomes of adjunct intravitreous (IVT) triamcinolone acetonide to antivascular endothelial growth factor (VEGF) injections to IVT anti-VEGF injections alone for center-involving diabetic macular edema (DME) in treatment-naïve eyes. Methods. Retrospective study o...
Autores principales: | Garoon, Robert B., Coffee, Robert E., Jiang, Lai, Weng, Christina Y., Carvounis, Petros E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5131249/ https://www.ncbi.nlm.nih.gov/pubmed/27980863 http://dx.doi.org/10.1155/2016/5282470 |
Ejemplares similares
-
Suprachoroidal versus Intravitreal Triamcinolone Acetonide for the Treatment of Diabetic Macular Edema
por: Zakaria, Yousra Gamal, et al.
Publicado: (2022) -
Intravitreal vs. subtenon triamcinolone acetonide for the treatment of diabetic cystoid macular edema
por: Cellini, Mauro, et al.
Publicado: (2008) -
Dose Dependent Effects of Intravitreal Triamcinolone Acetonide on Diffuse Diabetic Macular Edema
por: Bae, Joon Sung, et al.
Publicado: (2009) -
Intravitreal versus Posterior Subtenon Injection of Triamcinolone Acetonide for Diabetic Macular Edema
por: Choi, Young Jae, et al.
Publicado: (2006) -
Diabetic macular edema: Safe and effective treatment with intravitreal triamcinolone acetonide (Taioftal)
por: Sorrentino, Francesco Saverio, et al.
Publicado: (2021)